These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 16325931

  • 1. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
    Kaptein SJ, Efferth T, Leis M, Rechter S, Auerochs S, Kalmer M, Bruggeman CA, Vink C, Stamminger T, Marschall M.
    Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
    [Abstract] [Full Text] [Related]

  • 2. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J, De Clercq E.
    Verh K Acad Geneeskd Belg; 1994 Feb; 56(6):561-92. PubMed ID: 7892749
    [Abstract] [Full Text] [Related]

  • 3. Human cytomegalovirus DNA replication: antiviral targets and drugs.
    Mercorelli B, Sinigalia E, Loregian A, Palù G.
    Rev Med Virol; 2008 Feb; 18(3):177-210. PubMed ID: 18027349
    [Abstract] [Full Text] [Related]

  • 4. Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells.
    Schnepf N, Corvo J, Pors MJ, Mazeron MC.
    Antiviral Res; 2011 Feb; 89(2):186-8. PubMed ID: 21167209
    [Abstract] [Full Text] [Related]

  • 5. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
    Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG.
    Clin Infect Dis; 2008 May 01; 46(9):1455-7. PubMed ID: 18419454
    [Abstract] [Full Text] [Related]

  • 6. Novel inhibitors of human CMV.
    Andrei G, De Clercq E, Snoeck R.
    Curr Opin Investig Drugs; 2008 Feb 01; 9(2):132-45. PubMed ID: 18246516
    [Abstract] [Full Text] [Related]

  • 7. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
    Michaelis M, Ha TA, Doerr HW, Cinatl J.
    Cardiovasc Res; 2008 Feb 01; 77(3):544-50. PubMed ID: 18006438
    [Abstract] [Full Text] [Related]

  • 8. Effects of allitridin on acute and chronic mouse cytomegalovirus infection.
    Liu XL, Wang H, Li YN, Ge HX, Shu SN, Fang F.
    Arch Virol; 2011 Oct 01; 156(10):1841-6. PubMed ID: 21604182
    [Abstract] [Full Text] [Related]

  • 9. Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.
    Efferth T, Marschall M, Wang X, Huong SM, Hauber I, Olbrich A, Kronschnabl M, Stamminger T, Huang ES.
    J Mol Med (Berl); 2002 Apr 01; 80(4):233-42. PubMed ID: 11976732
    [Abstract] [Full Text] [Related]

  • 10. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Oiknine-Djian E, Weisblum Y, Panet A, Wong HN, Haynes RK, Wolf DG.
    Antimicrob Agents Chemother; 2018 Jul 01; 62(7):. PubMed ID: 29712656
    [Abstract] [Full Text] [Related]

  • 11. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.
    Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G.
    Antiviral Res; 2010 Mar 01; 85(3):532-40. PubMed ID: 20083141
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus.
    Akuzawa K, Yamada R, Li Z, Li Y, Sadanari H, Matsubara K, Watanabe K, Koketsu M, Tuchida Y, Murayama T.
    Antiviral Res; 2011 Sep 01; 91(3):296-303. PubMed ID: 21745500
    [Abstract] [Full Text] [Related]

  • 15. Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate.
    Milbradt J, Auerochs S, Korn K, Marschall M.
    J Clin Virol; 2009 Sep 01; 46(1):24-8. PubMed ID: 19501020
    [Abstract] [Full Text] [Related]

  • 16. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
    Kern ER, Rybak RJ, Hartline CB, Bidanset DJ.
    Antivir Chem Chemother; 2001 Sep 01; 12 Suppl 1():149-56. PubMed ID: 11594682
    [Abstract] [Full Text] [Related]

  • 17. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A, Champier G, Alain S, Petit F, Le Pors MJ, Mazeron MC.
    Antivir Ther; 2006 Sep 01; 11(4):537-40. PubMed ID: 16856628
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
    Wang Y, Mukhopadhyay R, Roy S, Kapoor A, Su YP, Charman SA, Chen G, Wu J, Wang X, Vennerstrom JL, Arav-Boger R.
    Antimicrob Agents Chemother; 2019 Jan 01; 63(1):. PubMed ID: 30373792
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY, Rybak RJ, Beadle JR, Gardner MF, Aldern KA, Wright KN, Kern ER.
    Antivir Chem Chemother; 2001 Jan 01; 12(1):61-70. PubMed ID: 11437323
    [Abstract] [Full Text] [Related]

  • 20. Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus.
    Drouot E, Piret J, Boivin G.
    Antivir Ther; 2016 Jan 01; 21(6):535-539. PubMed ID: 26844400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.